863 related articles for article (PubMed ID: 26133725)
21. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
Eldosoky MA; Hammad R; Elmadbouly AA; Aglan RB; Abdel-Hamid SG; Alboraie M; Hassan DA; Shaheen MA; Rushdi A; Ahmed RM; Abdelbadea A; Abdelmageed NA; Elshafei A; Ali E; Abo-Elkheir OI; Zaky S; Hamdy NM; Lambert C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834570
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
El-Hamouly MS; Azzam AA; Ghanem SE; El-Bassal FI; Shebl N; Shehata AMF
Mol Biol Rep; 2019 Dec; 46(6):5759-5765. PubMed ID: 31471732
[TBL] [Abstract][Full Text] [Related]
23. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
24. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma.
Fouad YM; Mohamed HI; Kamal EM; Rasek MA
Scand J Gastroenterol; 2016 Sep; 51(9):1133-7. PubMed ID: 27161933
[TBL] [Abstract][Full Text] [Related]
26. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
[TBL] [Abstract][Full Text] [Related]
28. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
29. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
30. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
31. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
Sun Q; Li J; Jin B; Wang T; Gu J
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
[TBL] [Abstract][Full Text] [Related]
33. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma.
Yin J; Hou P; Wu Z; Wang T; Nie Y
Tumour Biol; 2015 Jun; 36(6):4501-7. PubMed ID: 25618599
[TBL] [Abstract][Full Text] [Related]
34. Serum MicroRNA-122 and MicroRNA-155: Markers of Disease Progression in Hepatitis C viral infection.
Sheneef A; Gouda AM; Mohammad AN; Yousef LM; Noureldin AK
Egypt J Immunol; 2017 Jun; 24(2):33-46. PubMed ID: 29528577
[TBL] [Abstract][Full Text] [Related]
35. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
36. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
37. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
Chen Y; Chen J; Liu Y; Li S; Huang P
Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
[TBL] [Abstract][Full Text] [Related]
38. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients.
Demerdash HM; Hussien HM; Hassouna E; Arida EA
Biomed Res Int; 2017; 2017():1806069. PubMed ID: 28642869
[TBL] [Abstract][Full Text] [Related]
39. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma.
Shaker O; Alhelf M; Morcos G; Elsharkawy A
Infect Genet Evol; 2017 Jul; 51():173-181. PubMed ID: 28366737
[TBL] [Abstract][Full Text] [Related]
40. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]